American Chemical Society - 229th National Meeting. Carbohydrate vaccines: 13-17 March 2005, San Diego, CA, USA

David P. Rotella

American Chemical Society - 229th National Meeting. Carbohydrate vaccines: 13-17 March 2005, San Diego, CA, USA

Chemistry and Biochemistry

Research output: Contribution to journal › Article › peer-review

Abstract

The field of synthetic antibodies is an area that should be continually monitored. Pivotal clinical trials are underway with cancer vaccines, and synthetic HIV vaccines are moving into advanced preclinical studies. Cost issues are being addressed in an attempt to make the products affordable in poor countries where these vaccines are urgently needed.

Original language	English
Pages (from-to)	387-389
Number of pages	3
Journal	IDrugs
Volume	8
Issue number	5
State	Published - May 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{2860ede0aab54c829e7ae8e734cb7402,

title = "American Chemical Society - 229th National Meeting. Carbohydrate vaccines: 13-17 March 2005, San Diego, CA, USA",

abstract = "The field of synthetic antibodies is an area that should be continually monitored. Pivotal clinical trials are underway with cancer vaccines, and synthetic HIV vaccines are moving into advanced preclinical studies. Cost issues are being addressed in an attempt to make the products affordable in poor countries where these vaccines are urgently needed.",

author = "Rotella, {David P.}",

year = "2005",

month = may,

language = "English",

volume = "8",

pages = "387--389",

journal = "IDrugs",

issn = "1369-7056",

publisher = "Current Drugs Ltd.",

number = "5",

}

TY - JOUR

T1 - American Chemical Society - 229th National Meeting. Carbohydrate vaccines

T2 - 13-17 March 2005, San Diego, CA, USA

AU - Rotella, David P.

PY - 2005/5

Y1 - 2005/5

N2 - The field of synthetic antibodies is an area that should be continually monitored. Pivotal clinical trials are underway with cancer vaccines, and synthetic HIV vaccines are moving into advanced preclinical studies. Cost issues are being addressed in an attempt to make the products affordable in poor countries where these vaccines are urgently needed.

AB - The field of synthetic antibodies is an area that should be continually monitored. Pivotal clinical trials are underway with cancer vaccines, and synthetic HIV vaccines are moving into advanced preclinical studies. Cost issues are being addressed in an attempt to make the products affordable in poor countries where these vaccines are urgently needed.

UR - http://www.scopus.com/inward/record.url?scp=18144430284&partnerID=8YFLogxK

M3 - Article

C2 - 15883917

AN - SCOPUS:18144430284

SN - 1369-7056

VL - 8

SP - 387

EP - 389

JO - IDrugs

JF - IDrugs

IS - 5

ER -

American Chemical Society - 229th National Meeting. Carbohydrate vaccines: 13-17 March 2005, San Diego, CA, USA

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this